Tumor Lysis Syndrome after the Administration of Ruxolitinib in a Patient with Post-polycythemia Vera Myelofibrosis

The development of tumor lysis syndrome (TLS) in association with treatment for myeloproliferative neoplasms (MPNs) is relatively rare. We herein present the case of a post-polycythemia vera (PV) myelofibrosis patient with massive splenomegaly who developed laboratory TLS after treatment with ruxoli...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Intern Med
Autors principals: Koshiishi, Megumi, Sueki, Yuki, Kawashima, Ichiro, Nakajima, Kei, Mitsumori, Toru, Kirito, Keita
Format: Artigo
Idioma:Inglês
Publicat: The Japanese Society of Internal Medicine 2017
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5635310/
https://ncbi.nlm.nih.gov/pubmed/28794380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.8706-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars